Rasagiline mesylate

Min.Order / FOB Price:Get Latest Price

1 Gram	Negotiable

1 Gram

Negotiable

Min.Order :1 Gram
Purity: 99% purity
Payment Terms : T/T,,MoneyGram,Other

Keywords

161735-79-1 Rasagiline mesylate 99% purity

Quick Details

Appearance:powder
Application:intermediate
PackAge:According to the need of packing
ProductionCapacity:100|Kilogram|Month
Storage:2-8°C
Transportation:air,sea,courier

Superiority:

Product Name:   Rasagiline mesylate
Synonyms:   (1R)-2,3-Dihydro-N-2-propynyl-1H-inden-1-amine methanesulfonate;CS-289;R-(+)-Rasagiline mesylate;N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine methanesulfonate;Rasagiline Mesylate/Tartrate/Base;(1R)-2,3-Dihydro-N-2-propyn-1-yl-1H-inden-1-amine Mesylate;(R)-N-2-Propynyl-1-indanamine Mesylate;Agilect
CAS:   161735-79-1
MF:   C13H17NO3S
MW:   267.34398
EINECS:   694-423-3
Product Categories:   Chiral;Chiral Reagents;Intermediates & Fine Chemicals;Pharmaceuticals;Rasagiline;Signalling;APIs
Mol File:   161735-79-1.mol

Details:

Melting point    155-158°C
storage temp.    2-8°C
solubility    H2O: ≥20mg/mL
form    powder
color    white to tan
optical activity   [α]/D +15 to +28°, c = 0.6 mg/mL in H2O
CAS DataBase Reference   161735-79-1(CAS DataBase Reference)
Safety Information
Hazard Codes    Xn
Risk Statements    22
Safety Statements    24/25
WGK Germany    3
HS Code    29214990

Description   Rasagiline mesylate is a potent and selective irreversible monoamine oxidase B (MAO-B) inhibitor launched in 2005 in Israel by Teva as monotherapy in patients with early Parkinson's disease and as adjuvant treatment in moderate-toadvanced disease. Lundbeck will market the drug throughout Europe. Rasagiline is in phase II clinical trials at Teva and Eisai for the treatment of Alzheimer's type dementia.
Chemical Properties   White to Off-White Crystalline Solid
Uses   A selective irreversible MAO-B inhibitor. Antiparkinsonian
Uses   Rasagiline Mesylate is a new MAO-B inhibitor for the treatment of idiopathic Parkinson's disease.
Uses   Rasagiline is a selective irreversible MAO-B inhibitor. Rasagiline is an Antiparkinsonian agent.

View All